[Role of endocrine system in the development of experimental intestinal neoplasms].

K. M. Pozharisskii,V. Anisimov

Abstract:

What problem does this paper attempt to address?

Exploring the Role of the Gut Microbiota in Modulating Colorectal Cancer Immunity

Nikolay K. Shakhpazyan,Liudmila M. Mikhaleva,Arkady L. Bedzhanyan,Zarina V. Gioeva,Alexander I. Mikhalev,Konstantin Y. Midiber,Valentina V. Pechnikova,Andrey E. Biryukov

DOI: https://doi.org/10.3390/cells13171437

IF: 6

2024-08-29

Cells

Abstract:The gut microbiota plays an essential role in maintaining immune homeostasis and influencing the immune landscape within the tumor microenvironment. This review aims to elucidate the interactions between gut microbiota and tumor immune dynamics, with a focus on colorectal cancer (CRC). The review spans foundational concepts of immuno-microbial interplay, factors influencing microbiome composition, and evidence linking gut microbiota to cancer immunotherapy outcomes. Gut microbiota modulates anti-cancer immunity through several mechanisms, including enhancement of immune surveillance and modulation of inflammatory responses. Specific microbial species and their metabolic byproducts can significantly influence the efficacy of cancer immunotherapies. Furthermore, microbial diversity within the gut microbiota correlates with clinical outcomes in CRC, suggesting potential as a valuable biomarker for predicting response to immunotherapy. Conclusions: Understanding the relationship between gut microbiota and tumor immune responses offers potential for novel therapeutic strategies and biomarker development. The gut microbiota not only influences the natural history and treatment response of CRC but also serves as a critical modulator of immune homeostasis and anti-cancer activity. Further exploration into the microbiome's role could enhance the effectiveness of existing treatments and guide the development of new therapeutic modalities.

cell biology
EGFR Inhibition in a Pretreated Sacral Chordoma: A Role for Erlotinib? Case Report and a Brief Review of Literature

Dario Trapani,F. Conforti,T. D. Pas

DOI: https://doi.org/10.14273/UNISA-2684

2017-01-01

Abstract:We describe the case of a 69-year old male with an EGFR- positive Imatinib refractory sacral chordoma with synchronous lung metastases, treated with erlotinib, a first-generation EGFR inhibitor. After disease progression following first-line Imatinib and a combination therapy with everolimus plus metformin, we made a challenge with an EGFR tyrosine kinase inhibitor (EGFR TKI), erlotinib. Despite a brief clinical benefit, the patient presented a rapid clinical deterioration leading to death, after 8 weeks of treatment.
Advances in the role of gut microbiota in the regulation of the tumor microenvironment (Review)

Tian Xinyuan,Yu Lei,Shi Jianping,Zhao Rongwei,Shi Ruiwen,Zhang Ye,Zhao Jing,Tian Chunfang,Cui Hongwei,Guan Haibin

DOI: https://doi.org/10.3892/or.2023.8618

Abstract:As a protector of human health, the gut microbiota plays an important role in the development of the immune system during childhood, and the regulation of dietary habits, metabolism and immune system during adulthood. Dysregulated gut flora is not pathogenic, but it can weaken the protective effect of the immune system and cause various diseases. The tumor microenvironment is a physiological environment formed during tumor growth, which provides nutrients and growth factors necessary for tumor growth. As an important factor affecting the tumor microenvironment, the intestinal microflora affects the development of tumors through the mechanisms of gut and microflora metabolites, gene toxins and signaling pathways. The present article aimed to review the components and mechanisms of action, clinical applications, and biological targets of gut microbiota in the regulation of the tumor microenvironment. The present review provides novel insights for the future use of intestinal flora, to regulate the tumor microenvironment, to intervene in the occurrence, development, treatment and prognosis of tumors.
The Role of Intestinal Microbiota in Colorectal Cancer

Lingli Ren,Juan Ye,Bing Zhao,Jinbing Sun,Peng Cao,Yang Yang

DOI: https://doi.org/10.3389/fphar.2021.674807

IF: 5.6

2021-04-19

Frontiers in Pharmacology

Abstract:Colorectal cancer is a multifactorial disease involving genetic, environmental, and lifestyle risk factors. Intestinal microbiota plays an important role in the occurrence and development of colorectal cancer. Studies have shown that the behavior of intestinal microbiota can lead to pathological changes in the host intestine, which can be divided into epigenetic changes and carcinogenic changes at the gene level, and ultimately promote the formation and development of colorectal cancer. Intestinal microbiota is mainly distributed in the intestinal epithelium, which is composed of a large number of microorganisms interacting with the host intestinal cells. It can affect the immune-inflammation and metabolism of the gastrointestinal tract, and may be used as a biomarker for disease diagnosis. Regulation of gut microbiota is a promising strategy for the prevention and treatment of colorectal cancer. This article reviews the role of intestinal microbiota in the development of colorectal cancer, including the related mechanisms of intestinal microbiota promoting colorectal cancer, the use of intestinal microbiota in the diagnosis of colorectal cancer, and the regulation of intestinal microbiota in the prevention or treatment of colorectal cancer.

pharmacology & pharmacy
Emerging Roles of the Nervous System in Gastrointestinal Cancer Development

Chunhua Wan,Xiaoqin Yan,Baoying Hu,Xinhua Zhang

DOI: https://doi.org/10.3390/cancers14153722

2022-07-31

Cancers

Abstract:Our understanding of the fascinating connection between nervous system and gastrointestinal (GI) tumorigenesis has expanded greatly in recent years. Recent studies revealed that neurogenesis plays an active part in GI tumor initiation and progression. Tumor-driven neurogenesis, as well as neurite outgrowth of the pre-existing peripheral nervous system (PNS), may fuel GI tumor progression via facilitating cancer cell proliferation, chemoresistance, invasion and immune escape. Neurotransmitters and neuropeptides drive the activation of various oncogenic pathways downstream of neural receptors within cancer cells, underscoring the importance of neural signaling pathways in GI tumor malignancy. In addition, neural infiltration also plays an integral role in tumor microenvironments, and contributes to an environment in favor of tumor angiogenesis, immune evasion and invasion. Blockade of tumor innervation via denervation or pharmacological agents may serve as a promising therapeutic strategy against GI tumors. In this review, we summarize recent findings linking the nervous system to GI tumor progression, set the spotlight on the molecular mechanisms by which neural signaling fuels cancer aggressiveness, and highlight the importance of targeting neural mechanisms in GI tumor therapy.

oncology
The role of innate immune cells in the colorectal cancer tumor microenvironment and advances in anti-tumor therapy research

Wenxuan Liu,Tianrui Kuang,Li Liu,Wenhong Deng

DOI: https://doi.org/10.3389/fimmu.2024.1407449

IF: 7.3

2024-07-19

Frontiers in Immunology

Abstract:Innate immune cells in the colorectal cancer microenvironment mainly include macrophages, neutrophils, natural killer cells, dendritic cells and bone marrow-derived suppressor cells. They play a pivotal role in tumor initiation and progression through the secretion of diverse cytokines, chemokines, and other factors that govern these processes. Colorectal cancer is a common malignancy of the gastrointestinal tract, and understanding the role of innate immune cells in the microenvironment of CRC may help to improve therapeutic approaches to CRC and increase the good prognosis. In this review, we comprehensively explore the pivotal role of innate immune cells in the initiation and progression of colorectal cancer (CRC), alongside an extensive evaluation of the current landscape of innate immune cell-based immunotherapies, thereby offering valuable insights for future research strategies and clinical trials.

immunology
The Role of the Microbiome in the Etiopathogenesis of Colon Cancer

Geniver El Tekle,Natalia Andreeva,Wendy S Garrett,Wendy S. Garrett

DOI: https://doi.org/10.1146/annurev-physiol-042022-025619

IF: 22.162

2024-02-12

Annual Review of Physiology

Abstract:Studies in preclinical models support that the gut microbiota play a critical role in the development and progression of colorectal cancer (CRC). Specific microbial species and their corresponding virulence factors or associated small molecules can contribute to CRC development and progression either via direct effects on the neoplastic transformation of epithelial cells or through interactions with the host immune system. Induction of DNA damage, activation of Wnt/β-catenin and NF-κB proinflammatory pathways, and alteration of the nutrient's availability and the metabolic activity of cancer cells are the main mechanisms by which the microbiota contribute to CRC. Within the tumor microenvironment, the gut microbiota alter the recruitment, activation, and function of various immune cells, such as T cells, macrophages, and dendritic cells. Additionally, the microbiota shape the function and composition of cancer-associated fibroblasts and extracellular matrix components, fashioning an immunosuppressive and pro-tumorigenic niche for CRC. Understanding the complex interplay between gut microbiota and tumorigenesis can provide therapeutic opportunities for the prevention and treatment of CRC.

physiology
Role of gut microbiome in the outcome of cancer immunotherapy

Junting Ma,Wenwen Zhu,Beixing Liu

DOI: https://doi.org/10.1002/ijc.33524

2021-02-18

Abstract:Nearly 3 × 1013 types of bacteria colonize the human intestine. These colonized bacteria help in maintaining intestinal homeostasis by establishing a complex relationship with the intestinal epithelium and lymphoid tissue. Alteration in the composition of the intestinal microbiota is associated with susceptibility to various pathological conditions, such as autoimmune disorders, diabetes, inflammation and cancer. Of late, several researchers have focused on examining the effects of gut microbiota on the outcome of various cancer treatment protocols. Side effects and complications of traditional chemotherapy and allogeneic hematopoietic cell transplantation are associated with intestinal dysbiosis. Gut microbiota affects the efficacy of immune checkpoint inhibitor-based immunotherapy. The gut is inhabited by diverse resident bacteria, of which, few enhance, while others inhibit the host response to immunotherapy. This review focuses on the correlation between intestinal microbiota and the outcome of tumor immunotherapy. Additionally, the molecular mechanisms underlying the effects of gut microbiota on the efficacy of cancer immunotherapy have been reviewed. Further studies are needed for the identification of distinct gut microbiota and their efficacy in tumor immunotherapy as certain types of intestinal bacteria could function as novel adjuvant drugs to enhance the effectiveness of antitumor therapy in humans.
Gut Microbiota–MicroRNA Interactions in Intestinal Homeostasis and Cancer Development

Nataliia Nikolaieva,Aneta Sevcikova,Radoslav Omelka,Monika Martiniakova,Michal Mego,Sona Ciernikova

DOI: https://doi.org/10.3390/microorganisms11010107

IF: 4.5

2022-12-31

Microorganisms

Abstract:Pre-clinical models and clinical studies highlight the significant impact of the host–microbiota relationship on cancer development and treatment, supporting the emerging trend for a microbiota-based approach in clinical oncology. Importantly, the presence of polymorphic microbes is considered one of the hallmarks of cancer. The epigenetic regulation of gene expression by microRNAs affects crucial biological processes, including proliferation, differentiation, metabolism, and cell death. Recent evidence has documented the existence of bidirectional gut microbiota–microRNA interactions that play a critical role in intestinal homeostasis. Importantly, alterations in microRNA-modulated gene expression are known to be associated with inflammatory responses and dysbiosis in gastrointestinal disorders. In this review, we summarize the current findings about miRNA expression in the intestine and focus on specific gut microbiota–miRNA interactions linked to intestinal homeostasis, the immune system, and cancer development. We discuss the potential clinical utility of fecal miRNA profiling as a diagnostic and prognostic tool in colorectal cancer, and demonstrate how the emerging trend of gut microbiota modulation, together with the use of personalized microRNA therapeutics, might bring improvements in outcomes for patients with gastrointestinal cancer in the era of precision medicine.

microbiology
The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms

Sofía Frigerio,Dalia A Lartey,Geert R D'Haens,Joep Grootjans

DOI: https://doi.org/10.3390/ijms222312739

2021-11-25

Abstract:Patients with inflammatory bowel disease (IBD) have increased incidence of colorectal cancer (CRC). IBD-associated cancer follows a well-characterized sequence of intestinal epithelial changes, in which genetic mutations and molecular aberrations play a key role. IBD-associated cancer develops against a background of chronic inflammation and pro-inflammatory immune cells, and their products contribute to cancer development and progression. In recent years, the effect of the immunosuppressive microenvironment in cancer development and progression has gained more attention, mainly because of the unprecedented anti-tumor effects of immune checkpoint inhibitors in selected groups of patients. Even though IBD-associated cancer develops in the background of chronic inflammation which is associated with activation of endogenous anti-inflammatory or suppressive mechanisms, the potential role of an immunosuppressive microenvironment in these cancers is largely unknown. In this review, we outline the role of the immune system in promoting cancer development in chronic inflammatory diseases such as IBD, with a specific focus on the anti-inflammatory mechanisms and suppressive immune cells that may play a role in IBD-associated tumorigenesis.
O0036 COMMON FEATURES OF GUT DEVELOPMENT AND NEOPLASIA REFLECTED BY NPO GENE EXPRESSION

A. N. Mayer,R. E. Palmer,D. A. Haber

DOI: https://doi.org/10.1097/00005176-200406001-00038

2004-01-01

Journal of Pediatric Gastroenterology and Nutrition

Abstract:Journal of Pediatric Gastroenterology and NutritionVolume 39, Issue S1 p. S21-S21 ABSTRACTS: Oral Presentation Abstracts O0036 COMMON FEATURES OF GUT DEVELOPMENT AND NEOPLASIA REFLECTED BY NPO GENE EXPRESSION A. N. Mayer, A. N. Mayer Pediatric Gastroenterology, Medical College of Wisconsin, MilwaukeeSearch for more papers by this authorR. E. Palmer, R. E. Palmer Cancer Center, Massachusetts General Hospital, Boston, United StatesSearch for more papers by this authorD. A. Haber, D. A. Haber Cancer Center, Massachusetts General Hospital, Boston, United StatesSearch for more papers by this author A. N. Mayer, A. N. Mayer Pediatric Gastroenterology, Medical College of Wisconsin, MilwaukeeSearch for more papers by this authorR. E. Palmer, R. E. Palmer Cancer Center, Massachusetts General Hospital, Boston, United StatesSearch for more papers by this authorD. A. Haber, D. A. Haber Cancer Center, Massachusetts General Hospital, Boston, United StatesSearch for more papers by this author First published: 01 June 2004 https://doi.org/10.1002/j.1536-4801.2004.tb12344.x Submitted by: [email protected] Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Reference(S): 1)Mayer AN, Fishman MC. Development. 2003 Sep; 130(17): 3917–28. 10.1242/dev.00600 CASPubMedWeb of Science®Google Scholar 2)Jin SB, et al. J Biol Chem. 2002 May 24; 277(21): 18431–9. 10.1074/jbc.M112395200 CASPubMedWeb of Science®Google Scholar 3)Bjork P, et al. Mol Biol Cell. 2002 Oct; 13(10): 3683–95.7-28. 10.1091/mbc.e02-03-0138 CASPubMedWeb of Science®Google Scholar Volume39, IssueS1June 2004Pages S21-S21 ReferencesRelatedInformation
The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer

Qianqian Guo,Hai Qin,Xueling Liu,Xinxin Zhang,Zelong Chen,Tingting Qin,Linlin Chang,Wenzhou Zhang

DOI: https://doi.org/10.3389/fimmu.2022.915047

IF: 7.3

2022-06-16

Frontiers in Immunology

Abstract:The gut microbiota is composed of a large number of microorganisms with a complex structure. It participates in the decomposition, digestion, and absorption of nutrients; promotes the development of the immune system; inhibits the colonization of pathogens; and thus modulates human health. In particular, the relationship between gut microbiota and gastrointestinal tumor progression has attracted widespread concern. It was found that the gut microbiota can influence gastrointestinal tumor progression in independent ways. Here, we focused on the distribution of gut microbiota in gastrointestinal tumors and further elaborated on the impact of gut microbiota metabolites, especially short-chain fatty acids, on colorectal cancer progression. Additionally, the effects of gut microbiota on gastrointestinal tumor therapy are outlined. Finally, we put forward the possible problems in gut microbiota and the gastrointestinal oncology field and the efforts we need to make.

immunology
The fire within: microbes inflame tumors.

Nicola Gagliani,Bo Hu,Samuel Huber,Eran Elinav,Richard A Flavell

DOI: https://doi.org/10.1016/j.cell.2014.03.006

IF: 64.5

2014-01-01

Cell

Abstract:The immune system and the microbiota mutually interact to maintain homeostasis in the intestine. However, components of the microbiota can alter this balance and promote chronic inflammation, promoting intestinal tumor development. We review recent advances in understanding the complex interactions between the microbiota and the innate and adaptive immune systems and discuss their potential to lead us in new directions for understanding cancer biology and treatment.
From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?

Giovanni Vitale,Alessandra Dicitore,Luigi Barrea,Emilia Sbardella,Paola Razzore,Severo Campione,Antongiulio Faggiano,Annamaria Colao,Manuela Albertelli,Barbara Altieri,Filomena Bottiglieri,Federica De Cicco,Sergio Di Molfetta,Giuseppe Fanciulli,Tiziana Feola,Diego Ferone,Francesco Ferraù,Marco Gallo,Elisa Giannetta,Federica Grillo,Erika Grossrubatscher,Elia Guadagno,Valentina Guarnotta,Andrea M. Isidori,Andrea Lania,Andrea Lenzi,Fabio Lo Calzo,Pasquale Malandrino,Erika Messina,Roberta Modica,Giovanna Muscogiuri,Luca Pes,Genoveffa Pizza,Riccardo Pofi,Giulia Puliani,Carmen Rainone,Laura Rizza,Manila Rubino,Rosa Maria Ruggieri,Franz Sesti,Mary Anna Venneri,Maria Chiara Zatelli,

DOI: https://doi.org/10.1007/s11154-020-09589-y

2020-09-15

Reviews in Endocrine and Metabolic Disorders

Abstract:Abstract Gut microbiota is represented by different microorganisms that colonize the intestinal tract, mostly the large intestine, such as bacteria, fungi, archaea and viruses. The gut microbial balance has a key role in several functions. It modulates the host’s metabolism, maintains the gut barrier integrity, participates in the xenobiotics and drug metabolism, and acts as protection against gastro-intestinal pathogens through the host’s immune system modulation. The impaired gut microbiota, called dysbiosis, may be the result of an imbalance in this equilibrium and is linked with different diseases, including cancer. While most of the studies have focused on the association between microbiota and gastrointestinal adenocarcinomas, very little is known about gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs). In this review, we provide an overview concerning the complex interplay between gut microbiota and GEP NENs, focusing on the potential role in tumorigenesis and progression in these tumors.

endocrinology & metabolism
Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases

Haokun Shen,Zitong Zhao,Zengjue Zhao,Yuyi Chen,Linghua Zhang

DOI: https://doi.org/10.3390/ijms23020594

IF: 5.6

2022-01-06

International Journal of Molecular Sciences

Abstract:Intestinal homeostasis is a dynamic balance involving the interaction between the host intestinal mucosa, immune barrier, intestinal microecology, nutrients, and metabolites. Once homeostasis is out of balance, it will increase the risk of intestinal diseases and is also closely associated with some systemic diseases. Probiotics (Escherichia coli Nissle 1917, Akkermansia muciniphila, Clostridium butyricum, lactic acid bacteria and Bifidobacterium spp.), maintaining the gut homeostasis through direct interaction with the intestine, can also exist as a specific agent to prevent, alleviate, or cure intestinal-related diseases. With genetic engineering technology advancing, probiotics can also show targeted therapeutic properties. The aims of this review are to summarize the roles of potential native and engineered probiotics in oncology, inflammatory bowel disease, and obesity, discussing the therapeutic applications of these probiotics.

biochemistry & molecular biology,chemistry, multidisciplinary
The role of bidirectional communication between the adipokines and the endogenous opioid system in an experimental mouse model of colitis-associated colorectal cancer

Agata Szymaszkiewicz,Mikołaj Mierzejewski,Emilia Januszkiewicz,Weronika Machelak,Marcin Talar,Jakub Włodarczyk,Mikołaj Świerczyński,Radzisław Kordek,Jakub Fichna,Marta Zielińska

DOI: https://doi.org/10.1007/s43440-023-00566-1

2024-01-19

Pharmacological Reports

Abstract:Colorectal cancer (CRC) is one of the leading causes of death globally. Multiple factors may contribute to the pathogenesis of CRC, including the abnormalities in the functioning of the endogenous opioid system (EOS) or adiponectin-related signaling. The aim of our study was to evaluate if differences in the expression of opioid receptors (ORs) influence the development of CRC and if modulation of adiponectin receptors using AdipoRon, a selective AdipoR1 receptor agonist, affects colorectal carcinogenesis.

pharmacology & pharmacy
The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome

Xiaoyu Xue,Rui Li,Zhenni Chen,Guiyu Li,Bisheng Liu,Shanshan Guo,Qianhua Yue,Siye Yang,Linlin Xie,Yiguan Zhang,Junning Zhao,Ruirong Tan

DOI: https://doi.org/10.3389/fimmu.2023.1235827

IF: 7.3

2023-08-25

Frontiers in Immunology

Abstract:The gut microbiota is not just a simple nutritional symbiosis that parasitizes the host; it is a complex and dynamic ecosystem that coevolves actively with the host and is involved in a variety of biological activities such as circadian rhythm regulation, energy metabolism, and immune response. The development of the immune system and immunological functions are significantly influenced by the interaction between the host and the microbiota. The interactions between gut microbiota and cancer are of a complex nature. The critical role that the gut microbiota plays in tumor occurrence, progression, and treatment is not clear despite the already done research. The development of precision medicine and cancer immunotherapy further emphasizes the importance and significance of the question of how the microbiota takes part in cancer development, progression, and treatment. This review summarizes recent literature on the relationship between the gut microbiome and cancer immunology. The findings suggest the existence of a "symbiotic microecosystem" formed by gut microbiota, metabolome, and host immunome that is fundamental for the pathogenesis analysis and the development of therapeutic strategies for cancer.

immunology
The role of key gut microbial metabolites in the development and treatment of cancer

Kayla Jaye,Chun Guang Li,Dennis Chang,Deep Jyoti Bhuyan

DOI: https://doi.org/10.1080/19490976.2022.2038865

IF: 12.2

2022-02-27

Gut Microbes

Abstract:In recent years, the role of gut microbial metabolites on the inhibition and progression of cancer has gained significant interest in anticancer research. It has been established that the gut microbiome plays a pivotal role in the development, treatment and prognosis of different cancer types which is often mediated through the gut microbial metabolites. For instance, gut microbial metabolites including bacteriocins, short-chain fatty acids and phenylpropanoid-derived metabolites have displayed direct and indirect anticancer activities through different molecular mechanisms. Despite the reported anticancer activity, some gut microbial metabolites including secondary bile acids have exhibited pro-carcinogenic properties. This review draws a critical summary and assessment of the current studies demonstrating the carcinogenic and anticancer activity of gut microbial metabolites and emphasises the need to further investigate the interactions of these metabolites with the immune system as well as the tumour microenvironment in molecular mechanistic and clinical studies.

gastroenterology & hepatology,microbiology
Dietary and metabolic effects on intestinal stem cells in health and disease

Jessica E. S. Shay,Ömer H. Yilmaz

DOI: https://doi.org/10.1038/s41575-024-00980-7

2024-10-03

Nature Reviews Gastroenterology & Hepatology

Abstract:Diet and nutritional metabolites exhibit wide-ranging effects on health and disease partly by altering tissue composition and function. With rapidly rising rates of obesity, there is particular interest in how obesogenic diets influence tissue homeostasis and risk of tumorigenesis; epidemiologically, these diets have a positive correlation with various cancers, including colorectal cancer. The gastrointestinal tract is a highly specialized, continuously renewing tissue with a fundamental role in nutrient uptake and is, in turn, influenced by diet composition and host metabolic state. Intestinal stem cells are found at the base of the intestinal crypt and can generate all mature lineages that comprise the intestinal epithelium and are uniquely influenced by host diet, metabolic by-products and energy dynamics. Similarly, tumour growth and metabolism can also be shaped by nutrient availability and host diet. In this Review, we discuss how different diets and metabolic changes influence intestinal stem cells in homeostatic and pathological conditions, as well as tumorigenesis. We also discuss how dietary changes and composition affect the intestinal epithelium and its surrounding microenvironment.

gastroenterology & hepatology
The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy

Zijun Wang,Lanqing Li,Shunshun Wang,Jing Wei,Linghang Qu,Lianhong Pan,Kang Xu

DOI: https://doi.org/10.3389/fphar.2022.1025860

IF: 5.6

2022-11-14

Frontiers in Pharmacology

Abstract:Cancer is the second leading cause of elevated mortality worldwide. Thus, the development of drugs and treatments is needed to enhance the survival rate of the cancer-affected population. Recently, gut microbiota research in the healthy development of the human body has garnered widespread attention. Many reports indicate that changes in the gut microbiota are strongly associated with chronic inflammation-related diseases, including colitis, liver disease, and cancer within the intestine and the extraintestinal tract. Different gut bacteria are vital in the occurrence and development of tumors within the gut and extraintestinal tract. The human gut microbiome has significant implications for human physiology, including metabolism, nutrient absorption, and immune function. Moreover, diet and lifestyle habits are involved in the evolution of the human microbiome throughout the lifetime of the host and are involved in drug metabolism. Probiotics are a functional food with a protective role in cancer development in animal models. Probiotics alter the gut microbiota in the host; thus, beneficial bacterial activity is stimulated, and detrimental activity is inhibited. Clinical applications have revealed that some probiotic strains could reduce the occurrence of postoperative inflammation among cancer patients. An association network was constructed by analyzing the previous literature to explore the role of probiotics from the anti-tumor perspective. Therefore, it provides direction and insights for research on tumor treatment.

pharmacology & pharmacy

[Role of endocrine system in the development of experimental intestinal neoplasms].

Exploring the Role of the Gut Microbiota in Modulating Colorectal Cancer Immunity

EGFR Inhibition in a Pretreated Sacral Chordoma: A Role for Erlotinib? Case Report and a Brief Review of Literature

Advances in the role of gut microbiota in the regulation of the tumor microenvironment (Review)

The Role of Intestinal Microbiota in Colorectal Cancer

Emerging Roles of the Nervous System in Gastrointestinal Cancer Development

The role of innate immune cells in the colorectal cancer tumor microenvironment and advances in anti-tumor therapy research

The Role of the Microbiome in the Etiopathogenesis of Colon Cancer

Role of gut microbiome in the outcome of cancer immunotherapy

Gut Microbiota–MicroRNA Interactions in Intestinal Homeostasis and Cancer Development

The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms

O0036 COMMON FEATURES OF GUT DEVELOPMENT AND NEOPLASIA REFLECTED BY NPO GENE EXPRESSION

The Emerging Roles of Human Gut Microbiota in Gastrointestinal Cancer

The fire within: microbes inflame tumors.

From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell?

Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases

The role of bidirectional communication between the adipokines and the endogenous opioid system in an experimental mouse model of colitis-associated colorectal cancer

The role of the symbiotic microecosystem in cancer: gut microbiota, metabolome, and host immunome

The role of key gut microbial metabolites in the development and treatment of cancer

Dietary and metabolic effects on intestinal stem cells in health and disease

The role of the gut microbiota and probiotics associated with microbial metabolisms in cancer prevention and therapy